Published: 21 January 2022
Author(s): Sofia Tejada, Sergio Ramírez-Estrada, Alexandre M. Tejo, Carlos G. Forero, Xavier Pomares, Miguel Gallego, Joan B. Soriano, James D. Chalmers, Jordi Rello
Issue: April 2022
Section: Beyond the Guidelines

Bronchiectasis is a chronic respiratory disease, characterized clinically by a persistent cough, excessive sputum production, bronchial infection, and abnormal and permanent dilatation of the bronchi by radiologically [1]. Its prevalence has increased 40% in the last ten years and bronchiectasis is associated with a high level of morbidity and health care costs [1]. Only in the US, the economic costs have been estimated to be above 630 million dollars per year. Causes include pneumonia, tuberculosis and immune system problems (rheumatoid arthritis, Sjögren Syndrome or inflammatory bowel diseases), which are usually managed by internists.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.